Newswise — The American Institute of Physics (AIP), a highly-respected publisher of scholarly journals, magazines, and conference proceedings, and leading society publisher, and Collexis Holdings, Inc. (OTCBB: CLXS), a premier developer of semantic search and knowledge discovery software, announced today their new technology partnership. The innovative collaboration will allow AIP (www.aip.org) to leverage Collexis' proprietary technology within the physics market.
"As we embrace Web 2.0 functionality, we are also looking to a future that will most definitely rely on semantic publishing," said John Haynes, AIP's Vice President of Publishing. "We've been at the forefront of electronic publishing for 15 years, releasing the first online version of an established physics journal (Applied Physics Letters) in 1995; we've built upon that start through three generations of online services; and now, through our partnership with Collexis, we're ready to aggressively explore all opportunities presented by the semantic web. Look for product announcements flowing out of this partnership in the very near future."
"This unique partnership between AIP and Collexis will allow us to showcase our proprietary Fingerprinting technology to the physics community," states Bill Kirkland CEO of Collexis. "Further it validates that the STM market place is beginning to understand and embrace the benefits and efficiencies of the semantic technology. This partnership will encourage other AIP-affiliated publishers to explore these same knowledge discovery tools."
About the American Institute of Physics
American Institute of Physics is a federation of 10 physical science societies representing more than 135,000 scientists, engineers, and educators and is one of the world's largest publishers of scientific information in physics. Offering full-solution publishing services for scientific societies and for similar organizations in science and engineering, AIP is a leader in the field of electronic publishing of scholarly journals. AIP publishes 12 journals (some of which are the most highly cited in their respective fields), two magazines, including its flagship publication Physics Today; and the AIP Conference Proceedings series. Its online publishing platform Scitation hosts nearly two million articles from more than 185 scholarly journals and other publications of 28 learned society publishers.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with operations in Cincinnati, Ohio, Cologne, Germany and Valparaiso, Chile. Collexis now offers the world's first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.
Forward-Looking Statements for Collexis
Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with BiomedExperts.com. These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-K for the period ended June 30, 2008. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.
RSS